The novel data suggest that PD-L1-positive LEL may be a key player in the pathophysiology and morphogenesis of HP (NIH, category IV prostatitis) by mediating the self-sustained inflammatory immune/autoimmune processes in this chronic subclinical disease. Here, CD274 is linked to urogenital neoplasm.